Search Results - "SPECTOR, Stephen A"
-
1
Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy
Published in PLoS pathogens (01-05-2012)“…Low vitamin D levels in human immunodeficiency virus type-1 (HIV) infected persons are associated with more rapid disease progression and increased risk for…”
Get full text
Journal Article -
2
Human Immunodeficiency Virus Type 1 and Methamphetamine-Mediated Mitochondrial Damage and Neuronal Degeneration in Human Neurons
Published in Journal of virology (29-09-2020)“…Methamphetamine, a potent psychostimulant, is a highly addictive drug commonly used by persons living with HIV (PLWH), and its use can result in cognitive…”
Get full text
Journal Article -
3
HIV Type 1 gp120-Induced Expansion of Myeloid Derived Suppressor Cells Is Dependent on Interleukin 6 and Suppresses Immunity
Published in The Journal of infectious diseases (01-02-2014)“…Background, Factors responsible for myeloid-derived suppressor cell (MDSC) expansion and T-cell dysfunction during human immunodeficiency virus type 1 (HIV)…”
Get full text
Journal Article -
4
Current strategies to induce selective killing of HIV‐1‐infected cells
Published in Journal of leukocyte biology (01-11-2022)“…Although combination antiretroviral therapy (ART) has led to significant HIV‐1 suppression and improvement in immune function, persistent viral reservoirs…”
Get full text
Journal Article -
5
Human Immunodeficiency Virus Type 1 Nef Inhibits Autophagy through Transcription Factor EB Sequestration
Published in PLoS pathogens (01-06-2015)“…HIV Nef acts as an anti-autophagic maturation factor through interaction with beclin-1 (BECN1). We report that exposure of macrophages to infectious or…”
Get full text
Journal Article -
6
TREM-1 Protects HIV-1-Infected Macrophages from Apoptosis through Maintenance of Mitochondrial Function
Published in mBio (12-11-2019)“…Macrophages are a reservoir for latent human immunodeficiency type 1 (HIV) infection and a barrier to HIV eradication. In contrast to CD4 T cells, macrophages…”
Get full text
Journal Article -
7
Identification of a candidate therapeutic autophagy-inducing peptide
Published in Nature (London) (14-02-2013)“…The lysosomal degradation pathway of autophagy has a crucial role in defence against infection, neurodegenerative disorders, cancer and ageing. Accordingly,…”
Get full text
Journal Article -
8
SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway
Published in iScience (23-04-2021)“…Macrophages promote an early host response to infection by releasing pro-inflammatory cytokines such as interleukin-1β (IL-1β), TNF, and IL-6. The bioactivity…”
Get full text
Journal Article -
9
Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1
Published in PLoS pathogens (01-11-2012)“…Toll-like receptors (TLR) are important in recognizing microbial pathogens and triggering host innate immune responses, including autophagy, and in the…”
Get full text
Journal Article -
10
Autophagy induction by vitamin D inhibits both Mycobacterium tuberculosis and human immunodeficiency virus type 1
Published in Autophagy (01-10-2012)“…Low vitamin D levels in human immunodeficiency virus type-1 (HIV) infected persons are associated with more rapid disease progression and increased risk for…”
Get full text
Journal Article -
11
Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication
Published in The Journal of biological chemistry (20-04-2018)“…In this study, we investigated the effects of the dual phosphatidylinositol 3-kinase/mechanistic target of rapamycin (PI3K/MTOR) inhibitor dactolisib…”
Get full text
Journal Article -
12
Pacritinib Inhibition of IRAK1 Blocks Aberrant TLR8 Signalling by SARS-CoV-2 and HIV-1-Derived RNA
Published in Journal of innate immunity (01-01-2023)“…Abstract Macrophages promote an early host response to infection by releasing pro-inflammatory cytokines such as interleukin (IL) 1β (IL-1β), tumour necrosis…”
Get full text
Journal Article -
13
Autophagy Induction by Histone Deacetylase Inhibitors Inhibits HIV Type 1
Published in The Journal of biological chemistry (20-02-2015)“…Histone deacetylase inhibitors (HDACi) are being evaluated in a “shock-and-kill” therapeutic approach to reverse human immunodeficiency virus type-1 (HIV)…”
Get full text
Journal Article -
14
CD4 + T Cell-Mimicking Nanoparticles Broadly Neutralize HIV-1 and Suppress Viral Replication through Autophagy
Published in mBio (15-09-2020)“…Therapeutic strategies that provide effective and broad-spectrum neutralization against HIV-1 infection are highly desirable. Here, we investigate the…”
Get full text
Journal Article -
15
Associations of Genetically Determined Continental Ancestry With CD4+ Count and Plasma HIV-1 RNA Beyond Self-Reported Race and Ethnicity
Published in Journal of acquired immune deficiency syndromes (1999) (15-04-2016)“…BACKGROUND:Ancestry informative markers (AIMs) measure genetic admixtures within an individual beyond self-reported racial/ethnic (SRR) groups. Here, we used…”
Get full text
Journal Article -
16
Induction of Autophagy to Achieve a Human Immunodeficiency Virus Type 1 Cure
Published in Cells (Basel, Switzerland) (16-07-2021)“…Effective antiretroviral therapy has led to significant human immunodeficiency virus type 1 (HIV-1) suppression and improvement in immune function. However,…”
Get full text
Journal Article -
17
Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons
Published in Journal of virology (15-11-2018)“…HIV enters the central nervous system (CNS) during the early stages of infection and can cause neurological dysfunction, including neurodegeneration and…”
Get full text
Journal Article -
18
Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial
Published in Journal of the American Heart Association (22-05-2017)“…HIV infection and certain antiretroviral therapy (ART) medications increase atherosclerotic cardiovascular disease risk, mediated, in part, through traditional…”
Get full text
Journal Article -
19
CCL2 Increases X4-tropic HIV-1 Entry into Resting CD4+ T Cells
Published in The Journal of biological chemistry (07-11-2008)“…During human immunodeficiency virus type 1 (HIV-1) infection, there is a strong positive correlation between CCL2 levels and HIV viral load. To determine…”
Get full text
Journal Article -
20
Raltegravir Pharmacokinetics in Neonates Following Maternal Dosing
Published in Journal of acquired immune deficiency syndromes (1999) (01-11-2014)“…International Maternal Pediatric Adolescent AIDS Clinical Trials P1097 was a multicenter trial to determine washout pharmacokinetics and safety of in…”
Get full text
Journal Article